Evidence-Based Consulting in Drug Policy, Criminal Justice, and Public Health
Dr. Daniel Bear advises governments, health organizations, and NGOs on complex social policy challenges — drawing on two decades of research, policy analysis, and applied consulting across Canada, the USA, Europe, and Africa.
UK Ministry of Justice · Canadian Public Health Association · Mental Health Commission of Canada · Eastern and Southern Africa Commission on Drugs · Canadian Centre on Substance Use and Addiction · Ontario Cannabis Store · ERANID · Toronto Police Service · Release · Ideas Para La Paz · Canopy Growth Corporation
Dr. Daniel Bear is a policy researcher and consultant specializing in drug policy, harm reduction, and criminal justice reform. He holds a PhD in Social Policy from the London School of Economics and has spent two decades conducting research and advising organizations on policy and program challenges in Canada, the USA, the United Kingdom, Colombia, and across sub-Saharan Africa.
Responsum Consulting works with government ministries, national health organizations, NGOs, and regulated industry clients. Engagements range from multi-country research programs and program evaluations to policy advisory work, training development, and knowledge translation.
More about Dr. Bear
Government / Criminal Justice
Evaluating Violence Reduction in UK Prisons
Client: UK Ministry of Justice
A multi-site, mixed-methods evaluation of Structured Communication techniques across adult and youth correctional facilities, examining causes of officer-prisoner violence and measuring program effectiveness.
International Policy
Cannabis Policy Development Advisory:
Client: Eastern and Southern Africa Commission on Drugs
Invited by the ESACD to advise government delegations from eight countries on evidence-based approaches to cannabis regulation and drug policy reform, with workshops held in Botswana and Mozambique.
Public Health
Cannabis Education for Healthcare Providers
Client: Canadian Public Health Association
Redesigned and redeveloped the CPHA's cannabis education toolkit for frontline medical professionals, reorienting the content toward harm reduction and practical clinical guidance rather than risk-focused messaging.